Dec 21 World Preclinical Congress Europe
November 15th – 17th, 2017
Cyprio’s HepatoPearls made another appearance in the “3D cellular models; taking screening into a new dimension” session. While the HepatoPearls were being presented to the audience, Cyprio also presented the results of a collaborative project with Sanofi for high throughput drug-drug interaction screenings.
Our very own CEO, Noushin Dianat, was interviewed during the conference: